Erica Tsang

GI medical oncologist @pmcancercentre @uoftmedicine s/p @UCSFCancer @BCCancer | @AACR AMC #GICancer Tweets are my own, RT not endorsements.

[Erica Tsang @EricaTsangMD]

A plug for our @ALLIANCE_org trial for patients with BRCA1/2 or PALB2 mutant pancreas cancer! #NCTN #PancChat @EileenMOReilly @KReissMD @MPishvaian @efratdotan @HKennecke @Aiims1742 @GillSharlene @PanCAN @BasserBRCA @FacingOurRisk

[Alliance for Clinical Trials in Oncology @ALLIANCE_org]

Andrew Ko MD and @EricaTsangMD @UCSFCancer lead @ALLIANCE_org A022106 (PLATINUM) to compare two chemotherapy regimens to treat patients w/metastatic pancreatic cancer & BRCA1/2 or PALB2 mutations. Learn more: https://t.co/vICX5ZPqWs #NCI #NCTN @PanCAN @letswinpc #PancChat #PancSM

[Marathon of Hope Cancer Centres Network @marathonofhope]

💬 "I’m glad my data will play a role in bringing hope to more cancer patients" 💬

Precision oncology has given Dan Murphy new hope.
Now, he's sharing his story – and his data – to bring that hope to other patients.

🍁  Full story ▶ https://t.co/82yelY1rTw

[Grainne O'Kane @graokane]

PASS-01 trial #PDAC #ASCO24
➡️rand ph2 mFFX vs.GnP
➡️WGS/RNA/PDO/CTCs/ctDNA
✅PP PFS 5.5 (GnP) vs. 4.0mths (mFFX)
➡️PP ❌gBRCA/PALB2 >KRASWT in GnP
➡️MTB directed 2nd line
➡️ GnP remains a backbone for drug dvp
➡️basal-like unmet need
Proud @AmberHabowski as translational leads

[MunsterLab UCSF @munsterlab1]

A special evening today: Dr. Pamela Munster gets endowed with Mariam Moghadam Safinia distinguished professorship in hereditary cancer research
@UCSFCancer #breastcancer #Oncology #researchers

[Marathon of Hope Cancer Centres Network @marathonofhope]

🍁 MAESTRO: A Pan-Canadian project to accelerate #precisionmedicine for #pancreaticcancer🍁

🩺 Sadly, #PancreaticCancer is one of the deadliest cancers

🩺 Today, patients have very few treatment options, and those that exist are often ineffective

[Lillian Siu @lillian_siu]

@pmcancercentre looking forward to Cancer Genomics - Tumor Immunotherapy Program Annual Symposium on Friday Nov 10 in MaRS auditorium. Amazing line up of speakers 👏🔥 https://t.co/kSaT2O8kr6

[Grainne O'Kane @graokane]

RMC-6236 RAS-MULTI (ON) inhibitor
➡️promising activity in heavily pre-treated PDAC pts
➡️ORR 20% in 46 pts
➡️median time to response 1.4mths
➡️median time on tx 3.3 mths
✅ctDNA clearance >50% in 92%
➡️likely to need combinations but +exciting for PDAC #ESMO23 #PancreaticCancer

[Grainne O'Kane @graokane]

PREOPANC-2
➡️FFX vs Gemrads in resectable/
early BR #PancreaticCancer
➡️no diff in resection rates/OS/toxicity
❓recurrence patterns
➡️Nb full dose FFX
#ESMO23

[Lillian Siu @lillian_siu]

Such an honor to work with this super phase I team of PIs ⁦@pmcancercentre⁩ every day is an exciting day ⁦@salawuta⁩ ⁦@EricaTsangMD⁩ ⁦@LB_AR⁩ #anna_spreafico ⁦@Philippe_Bedard⁩ 🍁🍁🍁

[Tim Brown, MD MSCE @TimothyJBrownMD]

"Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer" commentary by Dr @EricaTsangMD and Dr Gallinger on our (@KReissMD) recent paper in @CCR_AACR
https://t.co/cUv4J1GDXl

[Grainne O'Kane @graokane]

Always a treat to hear @Aiims1742 describe RAS signalling and differences in KRAS mutant alleles in #PancreaticCancer pathogenesis
➡️ integration of transcriptomics to interrogate TME and metabolomics #abstract4020
✅ Differences certainly in G12D vs G12R

[WinC - AlinC (Women in Cancer - All in Cancer) @women_in_cancer]

T-1 week until our next Perspectives session in Chicago! @HornLeora @DrDanielHeng @DrCBrezden @lab_rezvani @ca_chung @maddynaseemMD #asco2023 #womeninmedicine

[Erica Tsang @EricaTsangMD]

@francescocay giving remarks as #AACRAMC President. Looking forward to our Professional Advancement Sessions for #ECRs #AACR23 @immunegirl @CampKatiee @KristinAltwegg

[Erica Tsang @EricaTsangMD]

So proud of @iryxie and all the Scholar in Training awardees for their amazing science and hard work!! #AACR23 #AACRAMC @AACR_CEO @francescocay @immunegirl @CampKatiee @jameshan_sj

[Katie Campbell @CampKatiee]

A great opportunity to support the next generation of cancer research @AACR the Undergraduate Student Poster Competition is open until 4PM #AACR23 #AACRGlobalScholars

[Francesco Caiazza @francescocay]

I had the best of times hearing about the research projects presented in the undergraduate student caucus and poster competition. So much enthusiasm and talent packed in a room! Thank you to the #AACRAMC judges @KristinAltwegg @waynerlawrence @MathiasSeviiri @safamajeed

[Sharlene Gill, MD, MPH, MBA, FASCO @GillSharlene]

Thank you @women_in_cancer - Women in Cancer / All in Cancer for the Keynote invitation 🙏

➡️ Strengthening through Perspectives
🗓️ Friday April 28th at 530pm EST
Faculty Club, University of Toronto

Join us 👉Register at https://t.co/GRCRYEQRhQ

#HappyInternationalWomensDay
@BCCancer @CAMO_ACOM @CDNCancerTrials @UBCDoM

[WinC - AlinC (Women in Cancer - All in Cancer) @women_in_cancer]

Happy International Women’s Day! Come join us Women-in-Cancer for our new series “Strengthening through Perspectives” and engage with our growing international community! Register at https://t.co/RFN9lah8v9 @DrCESimmons @DrCBrezden @HinaSaeedMD @IshwariaMD @belinda_campbe

[WinC - AlinC (Women in Cancer - All in Cancer) @women_in_cancer]

📣Today is the day - come join us and @amykpatel to hear about "Professional Success in Social Media" at 6:30pm CT.

DM for the Zoom link!

#SoMe #oncology @ca_chung @maguy_farhat @EricaTsangMD @JodiGoldman20

[Cancer Research Communications @CRC_AACR]

Just published! A phase Ib trial of the PI3K inhibitor alpelisib and weekly cisplatin in patients with solid tumor malignancies. Read more in this study by @EricaTsangMD et al.
https://t.co/WYCtvMfSYp
@UCSF #openaccess